Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-23

Clinical Trial Update: On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 clinical trial comparing on-demand silodosin 4 mg with dapoxetine 60 mg for primary premature ejaculation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapoxetine (dapoxetine)
  • Silodosin (Silodosin)

Snippet

Sponsor: Benha University | Conditions: Premature (Early) Ejaculation | Phase 2, Phase 3 | Status: COMPLETED